会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Microscope illumination device and adapter
    • 显微镜照明设备和适配器
    • US20070014002A1
    • 2007-01-18
    • US11487551
    • 2006-07-14
    • Vitaly VodyanoyOleg PustovyyArnold Vainrub
    • Vitaly VodyanoyOleg PustovyyArnold Vainrub
    • G02B21/06
    • G02B21/125
    • The present invention is a dark field illumination system including a light source which is fixed on an entrance slit of a condenser and an objective aligned with the condenser such that the objective and the condenser are adjusted to find a focus spot on a sample. The present invention essentially uses structured illumination to achieve an improved illumination system. The present invention also includes a system and method wherein the objective is coupled to an iris and aligned with the condenser such that when the iris is closed only dark field images are produced, and when the iris is open, direct entrance of light is allowed into the objective and bright field illumination is produced.
    • 本发明是一种暗场照明系统,其包括固定在冷凝器的入口狭缝上的光源和与冷凝器对准的物镜,使得调节物镜和聚光镜以在样品上找到焦点。 本发明基本上使用结构照明来实现改进的照明系统。 本发明还包括一种系统和方法,其中物镜耦合到虹膜并与冷凝器对准,使得当虹膜闭合时,仅产生暗场图像,并且当虹膜打开时,允许光直接进入 产生客观和明亮的场景照明。
    • 2. 发明申请
    • Strategy for designing patient-specific anti-cancer drugs
    • 设计患者特异性抗癌药物的策略
    • US20050260133A1
    • 2005-11-24
    • US11132879
    • 2005-05-19
    • Tatiana SamoylovaHenry BakerNancy CoxVitaly VodyanoyLudmila GlobaNancy Morrison
    • Tatiana SamoylovaHenry BakerNancy CoxVitaly VodyanoyLudmila GlobaNancy Morrison
    • A61K38/17A61K51/00C10G20060101G01N33/50G01N33/574
    • G01N33/574G01N33/5011G01N2500/10
    • A diagnostic technique for matching anti-cancer peptide drugs to the molecular profiles of individual cancer tumors, and a method using the technique for a patient-specific treatment of tumors in mammals. This strategy matches anti-cancer peptide drugs to the molecular profiles of individual tumors, and includes the development of two banks, both of which use the same targeting peptides. Targeting peptides are identified using biopsies or other tissue materials from multiple cancer patients and placed into two banks. For a bank of probes, targeting peptides are linked to a label such as a fluorescent or a radioisotope. For a bank of drugs, targeting peptides are linked to a cytotoxic peptide to form a “targeting peptide drug”. Peptide probes are used to establish molecular profiles of individual tumors. Based on these molecular profiles, a patient-specific combination of targeting drugs from the bank of peptide drugs is prepared and the patient is treated. Any currently used cytotoxic agent that can be linked to targeting peptides may be used in place of cytotoxic peptides.
    • 将抗癌肽药物与个体癌症肿瘤的分子特征匹配的诊断技术,以及使用该技术用于哺乳动物肿瘤患者特异性治疗的方法。 这种策略将抗癌肽药物与单个肿瘤的分子谱相匹配,并且包括两个银行的发展,两个银行都使用相同的靶向肽。 使用来自多个癌症患者的活组织检查或其他组织材料鉴定靶向肽,并将其置于两个组中。 对于一组探针,靶向肽与标记如荧光或放射性同位素连接。 对于一批药物,靶向肽与细胞毒肽连接以形成“靶向肽药物”。 肽探针用于建立单个肿瘤的分子谱。 基于这些分子谱,制备来自肽药物库的靶向药物的患者特异性组合,并对患者进行治疗。 可以使用任何目前使用的可以与靶向肽连接的细胞毒性剂来代替细胞毒性肽。